210 related articles for article (PubMed ID: 21787159)
1. Differences in bio-incompatibility among four biocompatible dialyzer membranes using in maintenance hemodialysis patients.
Zhang DL; Liu J; Cui WY; Ji DY; Zhang Y; Liu WH
Ren Fail; 2011; 33(7):682-91. PubMed ID: 21787159
[TBL] [Abstract][Full Text] [Related]
2. Biocompatibility and performance of a modified cellulosic and a synthetic high flux dialyzer. A randomized crossover comparison between cellulose triacetate and polysulphon.
Grooteman MP; Nubé MJ; van Limbeek J; van Houte AJ; Daha MR; van Geelen JA
ASAIO J; 1995; 41(2):215-20. PubMed ID: 7640431
[TBL] [Abstract][Full Text] [Related]
3. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study.
Traut M; Haufe CC; Eismann U; Deppisch RM; Stein G; Wolf G
Blood Purif; 2007; 25(5-6):432-40. PubMed ID: 17957097
[TBL] [Abstract][Full Text] [Related]
4. Does an alteration of dialyzer design and geometry affect biocompatibility parameters?
Opatrný K; Krouzzecký A; Polanská K; Mares J; Tomsů M; Bowry SK; Vienken J
Hemodial Int; 2006 Apr; 10(2):201-8. PubMed ID: 16623675
[TBL] [Abstract][Full Text] [Related]
5. Effects of low- and high-flux dialyzers on oxidative stress and insulin resistance.
Chu PL; Chiu YL; Lin JW; Chen SI; Wu KD
Blood Purif; 2008; 26(2):213-20. PubMed ID: 18285698
[TBL] [Abstract][Full Text] [Related]
6. The role of dialyzer membrane flux in bio-incompatibility.
Davenport A
Hemodial Int; 2008 Oct; 12 Suppl 2():S29-33. PubMed ID: 18837767
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of biocompatibility of hemophane, cellulose diacetate and acrilonitile membranes in hemodialysis].
Germin Petrović D
Acta Med Croatica; 2004; 58(1):31-6. PubMed ID: 15125391
[TBL] [Abstract][Full Text] [Related]
8. A new synthetic dialyzer with advanced permselectivity for enhanced low-molecular weight protein removal.
Krieter DH; Lemke HD; Wanner C
Artif Organs; 2008 Jul; 32(7):547-54. PubMed ID: 18638309
[TBL] [Abstract][Full Text] [Related]
9. Dialyzer membrane characteristics and outcome of patients with type 2 diabetes on maintenance hemodialysis.
Krane V; Krieter DH; Olschewski M; März W; Mann JF; Ritz E; Wanner C
Am J Kidney Dis; 2007 Feb; 49(2):267-75. PubMed ID: 17261429
[TBL] [Abstract][Full Text] [Related]
10. [Effects of hemodialysis membrane on serum lipid profile of maintenance hemodialysis patients].
Tanaka H; Nishikawa O; Yukawa S; Yoshimoto M; Nishide I
Nihon Jinzo Gakkai Shi; 1999 Jan; 41(1):1-7. PubMed ID: 10077981
[TBL] [Abstract][Full Text] [Related]
11. Clinical characterization of Dicea a new cellulose membrane for haemodialysis.
Hoenich NA; Woffindin C; Cox PJ; Goldfinch M; Roberts SJ
Clin Nephrol; 1997 Oct; 48(4):253-9. PubMed ID: 9352161
[TBL] [Abstract][Full Text] [Related]
12. Characterization of insulin adsorption behavior of dialyzer membranes used in hemodialysis.
Abe M; Okada K; Ikeda K; Matsumoto S; Soma M; Matsumoto K
Artif Organs; 2011 Apr; 35(4):398-403. PubMed ID: 21314833
[TBL] [Abstract][Full Text] [Related]
13. Biocompatibility and permeability of dialyzer membranes do not affect anemia, erythropoietin dosage or mortality in japanese patients on chronic non-reuse hemodialysis: a prospective cohort study from the J-DOPPS II study.
Yokoyama H; Kawaguchi T; Wada T; Takahashi Y; Higashi T; Yamazaki S; Fukuhara S; Akiba T; Akizawa T; Asano Y; Kurokawa K; Saito A;
Nephron Clin Pract; 2008; 109(2):c100-8. PubMed ID: 18596379
[TBL] [Abstract][Full Text] [Related]
14. Dialyzer reuse--part II: advantages and disadvantages.
Twardowski ZJ
Semin Dial; 2006; 19(3):217-26. PubMed ID: 16689973
[TBL] [Abstract][Full Text] [Related]
15. High-Performance Membrane Dialyzers and Mortality in Hemodialysis Patients: A 2-Year Cohort Study from the Annual Survey of the Japanese Renal Data Registry.
Abe M; Hamano T; Wada A; Nakai S; Masakane I
Am J Nephrol; 2017; 46(1):82-92. PubMed ID: 28675885
[TBL] [Abstract][Full Text] [Related]
16. The study of IL-1 beta, TNF-alpha, IL-6 gene expression and plasma levels on hemodialysis before and after dialyzer reuse.
Qian J; Yu Z; Dai H; Huang P; Zhang Q; Cheng F; Chen S
Chin Med J (Engl); 1997 Jul; 110(7):508-11. PubMed ID: 9594206
[TBL] [Abstract][Full Text] [Related]
17. Membrane biocompatibility does not affect whole body protein metabolism during dialysis.
Veeneman JM; Kingma HA; Stellaard F; de Jong PE; Reijngoud DJ; Huisman RM
Blood Purif; 2005; 23(3):211-8. PubMed ID: 15809504
[TBL] [Abstract][Full Text] [Related]
18. Prospective crossover trial of the influence of vitamin E-coated dialyzer membranes on T-cell activation and cytokine induction.
Girndt M; Lengler S; Kaul H; Sester U; Sester M; Köhler H
Am J Kidney Dis; 2000 Jan; 35(1):95-104. PubMed ID: 10620550
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory response of a new synthetic dialyzer membrane. A randomised cross-over comparison between polysulfone and helixone.
Stefoni S; Colì L; Cianciolo G; Donati G; Ruggeri G; Ramazzotti E; Pohlmeier R; Lang D
Int J Artif Organs; 2003 Jan; 26(1):26-32. PubMed ID: 12602466
[TBL] [Abstract][Full Text] [Related]
20. The impact of standard high-flux polysulfone versus novel high-flux polysulfone dialysis membranes on inflammatory markers: a randomized, single-blinded, controlled clinical trial.
Kerr PG; Sutherland WH; de Jong S; Vaithalingham I; Williams SM; Walker RJ
Am J Kidney Dis; 2007 Apr; 49(4):533-9. PubMed ID: 17386321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
